Pharmaceutical manufacturers of Remdesivir

At Esteve Quimica, we are dedicated to the healthcare sector by providing support for the advancement and commercialization of products that enhance the health of patients. Established in 1966, our company remains privately owned despite being a part of ESTEVE, one of the largest pharmaceutical groups in Spain. Our current focus is on the development and production of small molecule intermediates and active ingredients for innovator companies, operating as a dedicated third-party contract business.

Fisvi is a distinguished Italian company with a proud heritage in the manufacturing and innovation sectors. Specializing in advanced materials and cutting-edge solutions, Fisvi offers a wide range of products tailored to meet the demands of various industries, including construction, automotive, and industrial applications. Their product lineup includes high-quality insulation materials, adhesives, sealants, and other specialized components designed to enhance performance and durability.

Ami Lifesciences, established in 2006, is one of the fastest growing Active Pharmaceutical Ingredient (API) manufacturing companies in India, meeting unmet patient needs in various therapeutic areas such as Cardiovascular, Anti-Diabetics, CNS, and Respiratory amongst other categories, produced From Manufacturing unit located in Vadodara, Gujarat. We are recognised as a reliable supplier of generic APIs and a trustworthy Contract Development & Manufacturing partner for generic, Big Pharma & innovator pharmaceutical companies worldwide. We are among the leading manufacturers of APIs, intermediates and registered Key Starting Materials offering quality products with highest quality compliance & integrity to over 60+ countries. We believe, unlocking early launch opportunities, being cost competitive by virtue of backward integration and offering complete supply chain assurance is key to enable our customers to succeed & sustain their products through the product life cycle over a period of time.

We are a global vertically integrated pharmaceutical company engaged in research and development, manufacture, sale and distribution of prescription and OTC pharmaceutical products, with global presence in more than 50 countries, including United States, Europe, Canada, Japan, Australia and Rest of the World. We offer a wide range of proprietary finished dosage formulation catering to different therapeutic segments, including CVS, CNS, gastro-intestinal, etc. in multiple dosage forms including: Immediate-release oral solids Modified release oral solids MUPS based products Chewable tablets Powder for oral solutions & Suspensions

Aurore Life Sciences is a specialized manufacturer of active pharmaceutical ingredients (API) with a varied range of capabilities to enhance efficiency for generic pharmaceutical companies worldwide. Established in 2017 by a team with extensive expertise throughout the pharmaceutical supply chain, the company is dedicated to becoming the most favored partner for pharmaceuticals. At Aurore, we strive to innovate in the production and delivery of dependable high-quality products, earning the trust of both customers and regulatory bodies. Our focus on rapidly expanding capabilities has driven us to acquire, integrate, and extend our presence across multiple regions.

ZCL Chemicals Ltd operates as a 100% Export Oriented Unit (EOU) leveraging the potential of science and technology. It was founded in 1991, with its main office located in Mumbai. The R&D Center and cGMP-manufacturing facility is situated in the industrial hub of Ankleshwar city in Gujarat, approximately 300 kilometers north of Mumbai. This strategic location is well connected by Road, Rail, and Air, facilitating efficient cargo movement to the nearest major sea/airport, which is Mumbai. The company specializes in providing a diverse range of advanced fine chemical intermediates and actives.

Honour Lab Limited is based in India. The corporation's primary activity involves the production, crafting, or refinement of medications in pharmaceutical formulations for human or animal application.

Changzhou Pharmaceutical Factory (CPF) is a subsidiary company of Shanghai Pharma Holdings Co., Ltd., It is headquartered in Changzhou, Jiangsu province, China, Changzhou pharmaceutical Factory has a rich history & Lineage in the pharmaceutical sector. The company was founded in 1949 by (Tan Ruiting) with a registered capital 108 million yuan and the company was restructured as a Changzhou pharmaceutical Factory under the aegis of Shanghai Pharma Group. The Chinese business of Changzhou pharmaceutical factory was full fledged sales & marketing organization,Changzhou Pharma is a one of the prominent players in the Chinese pharmaceutical formulations market with a strong foothold across multiple therapies. The company have more than 1500 employees across the country and has earned a reputation amongest the Chinese pharmaceutical companies for providing innovative, comprehensive and complete healthcare solutions. At Changzhou pharmaceutical Factory, we have one of the strongest global commercial infrastructures in the industry, with a balanced reach across US, Europe, the Asia Pacific region and emerging markets. Our high quality manufacturing dedicated facilities for Oncology, Non Oncology, Complex Generics, OTC-Products and sterile injectables, scientific excellence and vast supply chain network to improve access to medicine for patients worldwide. The company mainly involves leading pharmaceutical manufacturer a wide range of key Intermediates, Active pharmaceutical ingredients, Finished Formulations meet with global standards, Changzhou Pharmaceutical Factory it covers an area of 300,000㎡ including R&D, dedicated manufacturing, international marketing office. And we maintain an industry -leading pipeline, composed of numerous complex generics and state owned brands. The company annually brings 800 tons of API's and 3000 millions of Finished dosage forms across the Globe.

Shree Venkatesh International Limited has established itself as a rapidly growing and distinguished Indian company dedicated to the production, promotion, and export of Hormonal products. Our state-of-the-art facility is equipped with advanced technologies specifically designed for a wide range of Gynecological, IVFs, and Contraceptives Hormonal products. At Shree Venkatesh International Limited, we tirelessly strive to develop highly efficient and safe hormonal products and make them accessible at the most competitive prices globally. Our portfolio includes Injectables, lyophilized powder, and hormonal Oral tablets, contributing to the enhancement of reproductive health on a global scale. Our WHO-GMP (India) plant has been inspected and approved by regulatory bodies in Yemen (SBDMA), Kenya (PPB), Nigeria (NAFDAC), Cambodia, and the Philippines. We have plans to extend our product reach to countries in the CIS, African, Southern Asian, Southern American, PIC/s, and MENA regions. For further information, please visit www.shreevenkatesh.com. Shree Venkatesh International Limited is an ISO9001:2008 Certified company registered under the Registrar of Companies Act, specializing in the export of Generic Medicines, Pharmaceutical formulations, and Bulk drugs from India. The company is based in Gujarat, which is renowned as the Manufacturing Hub for Pharmaceutical formulations in India.

Founded in 1993, the company specialized in manufacturing API’s and Intermediates with its manufacturing facility in Sadasivpet, Hyderabad (50 km from Rajiv Gandhi International Airport). In 1995, the company became a public listed company and was listed on the BSE. Everest Organics Limited is headed by seasoned professionals who have strong expertise in the field of medical science, marketing and business administration.

Jubilant HollisterStier Contract Manufacturing & Services is a fully integrated contract manufacturer that specializes in producing sterile injectables, ophthalmics, otics, and sterile and non-sterile topicals and liquids. Their facilities in North America and India offer specialized manufacturing services for the pharmaceutical and biopharmaceutical industries, with a strong emphasis on maintaining high-quality standards throughout their operations. They also provide a comprehensive range of support and services to optimize the manufacturing process, including on-site assistance for process qualifications and regulatory submittals.

Jiangsu Zenji Pharmaceuticals Ltd. is a national high-tech enterprise focusing on structural invention of drug innovation, research and application of new technologies, and the research and manufacture of characteristic generic drugs.There are two research and development institutes in Nanjing and Suzhou, two production bases in Huai'an and Suzhou, respectively, and a third production base under construction in Rizhao, Shandong. Currently, Zenji has about 900 employees, in which there are around 200 professional scientific research and technical personnel, with more than 30 people with a master's degree, a doctor’s degree or above, including many overseas returnees and foreign employees. The Executives are of medical, pharmaceutical, chemistry, and management professionals. Zenji focuses on the development and manufacture of antiviral, antitumor, cardio-cerebrovascular and digestive drugs. Antiviral drugs include Remdesivir, Favipiravir, Peramivir, Sofosbuvir, Ledipasvir, Velpatasvir, etc.; Antitumor drugs include Eribulin, Alectinib, Palbociclib, etc.; Cardio-cerebrovascular drugs include Colpidogrel Bisulfate, Citicoline sodium, Pitavastatin, etc.; Digestive drugs include Cimetidine, Famotidine, Rebamipide, etc. The company conducts research on innovative drugs through joint and independent development and obtains structural invention patents and technology application patents.